Hexiu Su
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
- Protein Degradation and Inhibitors
- RNA modifications and cancer
Papers in
-
- RNA modifications and cancer 2
- Epigenetics and DNA Methylation 2
- Ubiquitin and proteasome pathways 2
-
- Neuroblastoma Research and Treatments 4
- Co-authors
- Hudan Liu (10 shared papers)Guoliang Qing (9 shared papers)Yufeng Hu (6 shared papers)Daibiao Xiao (2 shared papers)Ming Yue (3 shared papers)Yue Ming (2 shared papers)Jue Jiang (2 shared papers)Feng Li (1 shared paper)
- Journals
- Scientific Reports (2 papers)Molecular Cancer Therapeutics (1 paper)Blood (1 paper)Nature Communications (1 paper)Oncotarget (1 paper)
- Partner nations
- ChinaUnited StatesBelgium
In The Last Decade
Hexiu Su
11 papers receiving 381 citations
Peers
Comparison fields: 5 of 55
- Cancer Research 124
- Molecular Biology 281
- Oncology 107
- Cell Biology 64
- Neurology 58
Countries citing papers authored by Hexiu Su
This map shows the geographic impact of Hexiu Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hexiu Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hexiu Su more than expected).
Fields of papers citing papers by Hexiu Su
This network shows the impact of papers produced by Hexiu Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hexiu Su. The network helps show where Hexiu Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Hexiu Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 121 | |
| 2 | 2020 | 79 | |
| 3 | 2015 | 67 | |
| 4 | 2016 | 29 | |
| 5 | 2014 | 26 | |
| 6 | 2018 | 24 | |
| 7 | 2020 | 23 | |
| 8 | 2020 | 9 | |
| 9 | 2017 | 3 | |
| 10 | 2014 | 1 | |
| 11 | 2018 | 1 |
About Hexiu Su
Hexiu Su is a scholar working on Molecular Biology, Neurology, Public Health, Environmental and Occupational Health, Surgery and Cell Biology, having authored 11 papers that have together received 383 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (4 papers), Neuroblastoma Research and Treatments (4 papers), Microtubule and mitosis dynamics (2 papers), RNA modifications and cancer (2 papers), Epigenetics and DNA Methylation (2 papers), Ubiquitin and proteasome pathways (2 papers), Chemical synthesis and alkaloids (1 paper) and Pharmacological Effects and Toxicity Studies (1 paper). The work is most often cited by research in Cancer Research (124 citations), Molecular Biology (281 citations), Oncology (107 citations), Cell Biology (64 citations) and Neurology (58 citations). Hexiu Su has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Hudan Liu, Guoliang Qing, Yufeng Hu, Daibiao Xiao, Ming Yue, Yue Ming, Jue Jiang, Feng Li, Hai‐Ning Du and Ping Ren. Their work appears in journals such as Scientific Reports, Molecular Cancer Therapeutics, Blood, Nature Communications and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.